An evaluation of the use of the Universal Benefit–Risk Assessment Framework by the Zambia Medicines Regulatory Authority for documenting and communicating benefit–risk decisions.

REGULATORY TOXICOLOGY AND PHARMACOLOGY · Published 2026-08-01 · DOI 10.1016/j.yrtph.2026.106204

Free full text

Authors (6)

Constance Sakala Chisha, Stephanie Leigh, Prudence Musonda Mubanga, Bernice Mumbi Chilufya, Makomani Siyanga, Stuart Walker

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Chisha, C., Leigh, S., Mubanga, P., et al. (2026). An evaluation of the use of the Universal Benefit–Risk Assessment Framework by the Zambia Medicines Regulatory Authority for documenting and communicating benefit–risk decisions.. REGULATORY TOXICOLOGY AND PHARMACOLOGY. https://doi.org/10.1016/j.yrtph.2026.106204

Related articles